Construction and evaluation of the functional polygenic risk score for gastric cancer in a prospective cohort of the European population

被引:0
|
作者
Gu, Yuanliang [1 ,2 ]
Yan, Caiwang [2 ,3 ,4 ]
Wang, Tianpei [2 ]
Hu, Beiping [2 ]
Zhu, Meng [2 ,3 ,4 ,5 ]
Jin, Guangfu [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 211166, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Key Lab Mol & Translat Canc Res,Affiliated, Nanjing 210009, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Polygenic risk score; Gastric cancer; Polymorphism; single nucleotide; Cross ancestry; GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; GENETIC RISK; PREDICTION; VARIANTS; ANNOTATION; MUTATIONS; FRAMEWORK;
D O I
10.1097/CM9.0000000000002716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:A polygenic risk score (PRS) derived from 112 single-nucleotide polymorphisms (SNPs) for gastric cancer has been reported in Chinese populations (PRS-112). However, its performance in other populations is unknown. A functional PRS (fPRS) using functional SNPs (fSNPs) may improve the generalizability of the PRS across populations with distinct ethnicities. Methods:We performed functional annotations on SNPs in strong linkage disequilibrium (LD) with the 112 previously reported SNPs to identify fSNPs that affect protein-coding or transcriptional regulation. Subsequently, we constructed an fPRS based on the fSNPs by using the LDpred2-infinitesimal model and then analyzed the performance of the PRS-112 and fPRS in the risk prediction of gastric cancer in 457,521 European participants of the UK Biobank cohort. Finally, the performance of the fPRS in combination with lifestyle factors were evaluated in predicting the risk of gastric cancer. Results:During 4,582,045 person-years of follow-up with a total of 623 incident gastric cancer cases, we found no significant association between the PRS-112 and gastric cancer risk in the European population (hazard ratio [HR] = 1.00 [95% confidence interval (CI) 0.93-1.09], P = 0.846). We identified 125 fSNPs, including seven deleterious protein-coding SNPs and 118 regulatory non-coding SNPs, and used them to construct the fPRS-125. Our result showed that the fPRS-125 was significantly associated with gastric cancer risk (HR = 1.11 [95% CI, 1.03-1.20], P = 0.009). Compared to participants with a low fPRS-125 (bottom quintile), those with a high fPRS-125 (top quintile) had a higher risk of incident gastric cancer (HR = 1.43 [95% CI, 1.12-1.84], P = 0.005). Moreover, we observed that participants with both an unfavorable lifestyle and a high genetic risk had the highest risk of incident gastric cancer (HR = 4.99 [95% CI, 1.55-16.10], P = 0.007) compared to those with both a favorable lifestyle and a low genetic risk. Conclusion:These results indicate that the fPRS-125 derived from fSNPs may act as an indicator to measure the genetic risk of gastric cancer in the European population.
引用
收藏
页码:1671 / 1679
页数:9
相关论文
共 50 条
  • [21] Association of the Polygenic Risk Score with the Incidence Risk of Parkinson's Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort
    Li, Wei-Wei
    Fan, Dong-Yu
    Shen, Ying-Ying
    Zhou, Fa-Ying
    Chen, Yang
    Wang, Ye-Ran
    Yang, Heng
    Mei, Jing
    Li, Ling
    Xu, Zhi-Qiang
    Wang, Yan-Jiang
    NEUROTOXICITY RESEARCH, 2019, 36 (03) : 515 - 522
  • [22] Polygenic Risk Score Improves Cataract Prediction in East Asian Population
    Hsu, Chih-Chien
    Chuang, Hao-Kai
    Hsiao, Yu-Jer
    Teng, Yuan-Chi
    Chiang, Pin-Hsuan
    Wang, Yu-Jun
    Lin, Ting-Yi
    Tsai, Ping-Hsing
    Weng, Chang-Chi
    Lin, Tai-Chi
    Hwang, De-Kuang
    Hsieh, Ai-Ru
    BIOMEDICINES, 2022, 10 (08)
  • [23] Polygenic Risk Score in Predicting Esophageal, Oropharyngeal, and Hypopharynx Cancer Risk among Taiwanese Population
    Huang, Yu-Che
    Lee, Ming-Ching
    Huang, Sheng-Yang
    Chou, Chia-Man
    Yang, Hui-Wen
    Chen, I-Chieh
    CANCERS, 2024, 16 (04)
  • [24] An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study
    Cheng, Yifei
    Wu, Lang
    Xin, Junyi
    Ben, Shuai
    Chen, Silu
    Li, Huiqin
    Zhao, Lingyan
    Wang, Meilin
    Cheng, Gong
    Du, Mulong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [25] Validation of a prostate cancer polygenic risk score
    Black, Mary H.
    Li, Shuwei
    LaDuca, Holly
    Lo, Min-Tzu
    Chen, Jefferey
    Hoiness, Robert
    Gutierrez, Stephanie
    Tippin-Davis, Brigette
    Lu, Hsiao-Mei
    Gielzak, Marta
    Wiley, Kathleen
    Shi, Zhuqing
    Wei, Jun
    Zheng, Siqun Lilly
    Helfand, Brian T.
    Isaacs, William
    Xu, Jianfeng
    PROSTATE, 2020, 80 (15) : 1314 - 1321
  • [26] The polygenic risk score in the breast cancer treatment
    Anaclerio, Federico
    Pilenzi, Lucrezia
    Minelli, Maria
    Giansante, Roberta
    Cicirelli, Michela
    Scorrano, Vincenzo
    Antonucci, Ivana
    Stuppia, Liborio
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2024, 8 (04) : 328 - 339
  • [27] Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort
    Wu, Yishuo
    Ruan, Xiaohao
    Gao, Peng
    Da, Huang
    Fang, Zujun
    Xu, Danfeng
    Jiang, Haowen
    Ding, Qiang
    Lin, Xiaoling
    Lu, Daru
    Na, Rong
    CLINICAL GENETICS, 2023, 103 (06) : 636 - 643
  • [28] A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population
    Akdeniz, Bayram Cevdet
    Mattingsdal, Morten
    Dominguez-Valentin, Mev
    Frei, Oleksandr
    Shadrin, Alexey
    Puustusmaa, Mikk
    Saar, Regina
    Sober, Siim
    Moller, Pal
    Andreassen, Ole A.
    Padrik, Peeter
    Hovig, Eivind
    CANCERS, 2023, 15 (16)
  • [29] Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case –control study
    J. C. Triviño
    A. Ceba
    E. Rubio-Solsona
    D. Serra
    I. Sanchez-Guiu
    G. Ribas
    R. Rosa
    M. Cabo
    L. Bernad
    G. Pita
    A. Gonzalez-Neira
    G. Legarda
    J. L. Diaz
    A. García-Vigara
    A. Martínez-Aspas
    M. Escrig
    B. Bermejo
    P. Eroles
    J. Ibáñez
    D. Salas
    A. Julve
    A. Cano
    A. Lluch
    R. Miñambres
    J. Benitez
    BMC Cancer, 20
  • [30] Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
    Levi, Hagai
    Carmi, Shai
    Rosset, Saharon
    Yerushalmi, Rinat
    Zick, Aviad
    Yablonski-Peretz, Tamar
    Wang, Qin
    Bolla, Manjeet K.
    Dennis, Joe
    Michailidou, Kyriaki
    Lush, Michael
    Ahearn, Thomas
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Antoniou, Antonis C.
    Arndt, Volker
    Augustinsson, Annelie
    Auvinen, Paivi
    Freeman, Laura Beane
    Beckmann, Matthias
    Behrens, Sabine
    Bermisheva, Marina
    Bodelon, Clara
    Bogdanova, Natalia V.
    Bojesen, Stig E.
    Brenner, Hermann
    Byers, Helen
    Camp, Nicola
    Castelao, Jose
    Chang-Claude, Jenny
    Chirlaque, Maria-Dolores
    Chung, Wendy
    Clarke, Christine
    Collee, Margriet J.
    Colonna, Sarah
    Couch, Fergus
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Daly, Mary
    Devilee, Peter
    Dork, Thilo
    Dossus, Laure
    Eccles, Diana M.
    Eliassen, A. Heather
    Eriksson, Mikael
    Evans, Gareth
    Fasching, Peter
    Fletcher, Olivia
    Flyger, Henrik
    JOURNAL OF MEDICAL GENETICS, 2023, 60 (12) : 1186 - 1197